Ndjeka, Norbert; Ismail, Nazir Ahmed
(Elsevier, 2020-08)
Bedaquiline, a novel therapeutic drug, and clofazimine, a
re-purposed drug, are front-line therapies recommended
by WHO to treat rifampicin-resistant or multidrugresistant
tuberculosis. Both drugs have been in use ...